Doctor profile · Federal record

Dr. Michael Gross, M.D.

Urology Physician (CMS: Urology) · Plano, TX

  • NPI 1447207493
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 37 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
6124 W Parker RD, Suite 434
Plano, TX 750938122
(214) 691-1902
fax (214) 987-1845
Mailing address
3600 Gaston Ave, Suite 1205
Dallas, TX 752461800

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
January 31, 2017
Year of graduation
1989 — 37 yrs since
Specialty taxonomy
208800000X — NUCC code
State license (1)
Texas #H8091
Medicaid (2)
TX #118934202 · TX #118934201

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1447207493. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
10,571
Distinct HCPCS
10
Medicare allowed
$342,356
HCPCS Description Services Patients Avg allowed
J1050 Injection, medroxyprogesterone acetate, 1 mg 4,752 18 $0
81001 Manual urinalysis test with examination using microscope, automated 1,139 756 $3
J0897 Injection, denosumab, 1 mg 966 16 $23
99213 Established patient office or other outpatient visit, 20-29 minutes 702 520 $88
99214 Established patient office or other outpatient visit, 30-39 minutes 500 371 $124
51798 Ultrasound measurement of bladder capacity after voiding 421 335 $10
36415 Insertion of needle into vein for collection of blood sample 359 256 $8
84153 Psa (prostate specific antigen) measurement, total 277 205 $18
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 271 40 $171
99204 New patient office or other outpatient visit, 45-59 minutes 176 176 $162

In context: peer comparison

Among 7 peers in this city , average services per provider: 213. This provider delivers 50× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,957
Transactions
68
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 16 $226.98
Sumitomo Pharma America, Inc. 7 $176.77
AXOGEN 2 $161.52
Janssen Biotech, Inc. 6 $127.33
Ferring Pharmaceuticals Inc. 5 $125.77
Dendreon Pharmaceuticals LLC 4 $124.07
Tempus AI, Inc 5 $120.22
Bayer Healthcare Pharmaceuticals Inc. 6 $103.77
Axonics, Inc. 3 $72.25
Edap Technomed Inc 3 $72.00
PFIZER INC. 3 $70.01
Merck Sharp & Dohme LLC 3 $68.91
Novartis Pharmaceuticals Corporation 2 $63.68
KOELIS Inc. 1 $53.56
UROGEN PHARMA, INC. 2 $46.84

By nature of payment

Food and Beverage
$1,957

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,424
Patients
961
Total drug cost
$1,514,254
Drug Type Claims Patients Total cost
Tamsulosin Hcl Generic 1,046 353 $23,095
Finasteride Generic 301 102 $4,792
Myrbetriq (Mirabegron) Brand 166 43 $140,630
Oxybutynin Chloride Er (Oxybutynin Chloride) Brand 134 47 $7,770
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 126 97 $712
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 104 98 $440
Testosterone Cypionate Generic 94 38 $5,436
Alfuzosin Hcl Er (Alfuzosin Hcl) Brand 77 25 $2,107
Erleada (Apalutamide) Brand 76 11 $1,134,984
Nitrofurantoin (Nitrofurantoin Macrocrystal) Brand 67 26 $4,090

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Gross's medical specialty?
Dr. Michael Gross practices Urology Physician in Plano, TX.
Where does Dr. Michael Gross practice?
Dr. Michael Gross practices at 6124 W Parker RD, Plano, TX 750938122. Office phone: 2146911902.
What is Dr. Michael Gross's NPI?
Dr. Michael Gross's National Provider Identifier (NPI) is 1447207493, issued by NPPES.
Does Dr. Michael Gross accept Medicare assignment?
Yes. Dr. Michael Gross accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Gross commonly perform?
Top Medicare-reported procedures in 2023: Injection, medroxyprogesterone acetate, 1 mg (HCPCS J1050); Manual urinalysis test with examination using microscope, automated (HCPCS 81001); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.